Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell lines
Journal of Blood Disorders & Transfusion

Journal of Blood Disorders & Transfusion
Open Access

ISSN: 2155-9864

+44 7460731551

Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell lines

4th International Conference on Blood Malignancies & Treatment

April 18-19, 2016 Dubai, UAE

Amani Mahbub, Le Maitre C L, Haywood-Small S L, Cross N A and Jordan-Mahy N

Umm al-Qura University, Saudi Arabia
Sheffield Hallam University, UK

Scientific Tracks Abstracts: J Blood Disord Transfus

Abstract :

Background: The study aimed to assess the effects of polyphenol when used in combination with doxorubicin and etoposide, and determine whether polyphenols sensitized leukaemia cells, causing cell-cycle arrest, inhibition of cell proliferation and induction of apoptosis. The rationale being that in some solid tumours, polyphenols have been shown to sensitize cells to apoptosis and/or cell-cycle arrest, potentially reducing doses, whilst maintaining efficacy. Method: Quercetin, apigenin, emodin, rhein, cis-stilbene were investigated alone and in combination with etoposide and doxorubicin in two lymphoid (JURKAT and CCRF-CEM) and two myeloid (THP-1 and KG-1a) leukaemia cells lines. Measurements were made of ATP levels (CellTiter-Glo®assay), cell-cycle progression (propidium iodide (PI) staining and flow cytometry) and apoptosis (NucView-caspase-3 assay and Hoechst 33342/PI staining). The effects of these combinations on the apoptotic pathway (caspases-3, -8 and -9 Glo®luminescent assays), glutathione levels (GSH-Glo™-glutathione assay and cell tracker™ green-5-chloromethylfluorescein-diacetate-glutathione staining) and DNA damage (Alexa Fluor® 647 Mouse anti- H2AX staining) were also determined. Results: Doxorubicin and etoposide in combination with polyphenols synergistically reduced ATP levels, induced apoptosis and increased S- and/or G2/M-phase cell-cycle arrest in lymphoid leukaemia cell lines. In the myeloid cell lines, doxorubicin and etoposide displayed differential effects. Doxorubicin had a synergistic or additive effect when combined with quercetin, apigenin, emodin, and cis-stilbene, but had an antagonistic effect when combined with rhein. Combination treatment caused a synergistic down regulation of glutathione (GSH) levels and increased DNA damage, driving apoptosis via caspase 8 and 9 activation. However, in myeloid cells were an antagonist effect this was associated with an up-regulation of GSH levels, a reduction in DNA damage and apoptosis. Conclusion: Doxorubicin and etoposide activity can be enhanced by polyphenols, particularly in lymphoid leukaemia cells, although effects were strongly dependent on type of cell line, with some interactions were antagonistic in myeloid cell lines.

Biography :

Amani Mahbub has completed M.Sc. in Biomedical Basis of Disease in 2010 and PhD in Anti-Cancer Potential of Polyphenols in Treatment of Leukemia in 2015 at the Sheffield Hallam University of Biomedical Research Centre – Cancer Research, Sheffield, UK. She has been interested in investigating the biological effects of a number of nutraceutical compounds such as polyphenols alone and in combination with chemotherapies on the induction of apoptosis, reduced cell proliferation and signalling pathways that involved in the pathogenesis of leukaemias. She also has four published papers in the Journal of Pathology (2012), the Journal of Anti-cancer Agents in Medicinal Chemistry (2013) and recently two in Nature (2015). In addition, she was awarded, the Alastair Currie prize for the best poster presentation at the Pathological Society of Great Britain & Ireland Conference in 2012, Sheffield, UK. Currently, she is working at Umm Al-Qura University in Applied Medical Sciences College– Pathology Department, Makkah, KSA.

Email: [email protected]